Senior black man and his middle aged daughter using a laptop together at home, close up

Respiratory Syncytial Virus (RSV) Vaccine Clinical Trial

Ages

18 and Over

Location

Columbus, OH

Compensation

For qualified participants
Senior black man and his middle aged daughter using a laptop together at home, close up

Respiratory Syncytial Virus (RSV) Vaccine Clinical Trials in Columbus

Aventiv Research is currently participating in a respiratory syncytial virus (RSV) vaccine study at our Columbus, Ohio location. Severe infection with RSV can lead to pneumonia and bronchiolitis and may require hospital care. People at greatest risk of severe infection are the very young (those less than six months old), those over the age of 65, and those of any age who have heart or lung conditions or a weakened immune system. RSV can also make existing heart and lung problems worse. Like any other drug, a new vaccine must be tested on human subjects before being approved for use by the Federal Drug Administration (FDA).

Enroll Now

Respiratory Syncytial Virus (RSV) Vaccine Clinical Trial

The primary objective of this clinical trial is to evaluate the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine in healthy adults. You may qualify for this study if you are:

  • A healthy volunteer who is at least 18 years old and overtly healthy as determined by medical evaluation

AND

  • Have not received any other licensed or investigational RSV vaccine preceding the trial vaccination

As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.

Ready to Volunteer?

Volunteer today to see if you qualify for our respiratory syncytial virus (RSV) vaccine clinical research study. Qualified volunteers may be compensated for time and travel.